Evidence map›Paper›PMID 40313415›Full record

ArticleJournal of extracellular biology2025

Characterization of Extracellular Vesicles Derived From Human Precision-Cut Liver Slices in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yana Geng, Ke Luo, Janine Stam, Dorenda Oosterhuis, Alan R Gorter, Marius van den Heuvel, Rossella Crescitelli, Vincent E de Meijer, Justina C Wolters, Peter Olinga

Abstract read
In one paragraph

Article in Journal of extracellular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yana GengDepartment of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands.ORCID https://orcid.org/0000-0003-1529-0875
Ke LuoDepartment of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands.
Janine StamDepartment of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands.
Dorenda OosterhuisDepartment of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands.
Alan R GorterDepartment of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands.
Marius van den HeuvelDivision of Pathology, Department of Pathology and Medical Biology University of Groningen, University Medical Center Groningen Groningen the Netherlands.
Rossella CrescitelliDepartment of Surgery, Sahlgrenska Center for Cancer Research and Wallenberg Centre for Molecular and Translational Medicine, Institute of Clinical Sciences Sahlgrenska Academy, University of Gothenburg Göteborg Sweden.ORCID https://orcid.org/0000-0002-1714-3169
Vincent E de MeijerDepartment of Surgery, Section of Hepatobiliary Surgery & Liver Transplantation University of Groningen, University Medical Center Groningen Groningen the Netherlands.
Justina C WoltersDepartment of Pediatrics University Medical Center Groningen, University of Groningen Groningen the Netherlands.
Peter OlingaDepartment of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are cell-produced, membrane-surrounded vesicles that harbour the biological features of donor cells. In the current study, we are the first to isolate and characterize EVs isolated from human precision-cut liver slices (PCLS), obtained from both healthy and metabolic dysfunction-associated steatohepatitis (MASH) cirrhotic livers. PCLS derived from patients can faithfully represent disease conditions in humans. EVs were isolated from human PCLS after incubating in normal medium or modified medium that mimics the pathophysiological environment of metabolic dysfunction associated liver disease (MASLD). MASH PCLS produced higher amounts of EVs compared to healthy PCLS (

Indexed as

biomarkerhepatic fibrosishuman precision‐cut liver slicesmetabolic dysfunction‐associated steatohepatitisproteomics

Identifiers

PMID40313415
PMCPMC12042696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.